Resources for Food and Drug Administration (FDA)
FDA Experts Favor Caridome Heart Drug
money.cnn.com A panel of heart experts on Tuesday recommended U.S. approval for Cardio Pharma's injectable drug to stop irregular heart rhythms.
Outside advisers for the Food and Drug Administration voted 6 to 2 in favor of vernakalant, which showed positive results at treating patients experiencing atrial fibrillation, which causes the heart's upper chambers to contract randomly. FDA is not required to follow the advice of its panels, though it usually does. It is scheduled to make a final decision on vernakalant by Jan. 19.
If the drug is approved, Japanese drug maker Astellas Pharma will have exclusive marketing rights in North America, under an agreement signed with Cardiome in 2003.
View the Resource
Share or bookmarklet this web page at:
|
RSS Feeds
